It was observed that knockout of the USP18 gene in mouse embryonic fibroblasts and knockdown of USP18 expression in the human hepatoma cell line Huh7.5 lead to prolonged responsiveness to IFNα and enhanced antiviral efficacy against HCV (Randall et al, 2006). The gene discussed is IFNA1; the disease is hepatocellular carcinoma.